Swan Valley Medical
Swan Valley Medical develops the T-SPeC® single-use suprapubic catheter placement device and the Swan Informatics™ predictive analytics platform, selling directly to U.S. hospitals and urologists to reduce catheter-related complications, hospital-acquired infections, and associated costs.
- Company typePrivate
- Founded2005
- HeadquartersBigfork, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Swan Valley Medical does
Swan Valley Medical, Incorporated is a privately-held medical device company headquartered in Bigfork, Montana, founded to address what its co-founder, the late Dr. Kenneth High, characterized as unsafe, unreliable, and poorly designed products in the urological catheter space. The company's flagship product is the T-SPeC® Instrument, a single-use suprapubic cystostomy catheter placement device that employs a proprietary 'inside-to-out' technique designed to virtually eliminate the risk of small bowel perforation associated with traditional 'outside-to-in' methods, while enabling procedure times under ten minutes. The company's second core product, Swan Informatics™, is a predictive analytics platform that processes evidence from more than 500 clinical study references and multiple healthcare databases to quantify preventable clinical complications, mortalities, and resulting cost savings for each hospital customer. The two products are positioned as a combined offering in which the T-SPeC® instrument generates the clinical use case that Swan Informatics™ translates into financial and outcome analyses for hospital decision-makers. The supporting product surface includes a gated Clinical Reference Access Program (NDA + access code) and a Training service currently listed as 'Under Development.'\n\nThe company operates a sales-led, enterprise field-sales go-to-market, selling T-SPeC® directly to U.S. hospitals and targeting the Financial Management, Risk Management, Materials Management, and Compliance departments in addition to physician champions, primarily urologists and interventional radiologists. Revenue is generated through hardware sales of the single-use instrument; pricing is not publicly disclosed. The company is also actively raising capital through SEC Regulation D Rule 506(b) exempt offerings to accredited investors, with a $6 million target filed in both June 2023 and July 2024, and cumulative equity funding of approximately $22 million raised to date primarily through Swan Capital, LLC, the family office of CEO and co-founder Ronald E. Zook. The leadership team includes a CMO with 100+ suprapubic placements, a CFO consultant with 35+ years in medical devices, a Chief Nursing Officer, a Director of Quality Assurance & Regulatory Affairs, and a recently retired hospital CEO serving as a consultant, reflecting a deliberate alignment of the company to hospital procurement and clinical committees.
Swan Valley Medical firmographics
Firmographics- Name
- Swan Valley Medical
- Legal name
- Swan Valley Medical, Incorporated
- Website
- https://swanvalleymedical.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Swan Valley Medical develops the T-SPeC® single-use suprapubic catheter placement device and the Swan Informatics™ predictive analytics platform, selling directly to U.S. hospitals and urologists to reduce catheter-related complications, hospital-acquired infections, and associated costs.
- Ownership category
- akta.pro rank
Swan Valley Medical industry classification
Industry- Product category
- Urological Surgical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
- akta.pro secondary industries
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN), Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF)
Keywords
Where Swan Valley Medical is headquartered
LocationHeadquarters
- HQ city
- Bigfork
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Swan Valley Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: The company generates revenue through the sale of its T-SPeC® medical instruments to hospitals and healthcare facilities. The device is sold as a medical product for suprapubic catheter placement procedures.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Swan Valley Medical product offering
Product offeringCore offering
Swan Valley Medical designs, develops, and manufactures single-use minimally invasive urological surgical instruments. Its flagship product, the T-SPeC® (Transcutaneous Suprapubic Endoscopic Cystostomy) system, enables suprapubic cystostomy catheter placement through a single small incision. The company also markets Swan Informatics™, a predictive analytics platform, alongside a Clinical Reference Access program for clinicians.
Product overview
Swan Valley Medical offers a unified product portfolio centered on two core offerings: Swan Informatics™ and T-SPeC®. Swan Informatics™ is a predictive analytics platform that processes clinical data from over 500 study references to quantify hospital outcomes and cost savings. T-SPeC® is the enabling medical instrument that provides an innovative 'inside-to-out' technique for suprapubic catheter placement, fundamentally changing urethral catheter practices that have remained virtually unchanged for over 100 years. These products work together—the T-SPeC® instrument generates clinical data that feeds into the Swan Informatics™ predictive analytics platform, which then delivers quantified improvements in clinical outcomes and hospital cost reductions. Additional services include clinical reference access and training programs.
Differentiator
Problem solved
Functional benefit
Brands
- Swan Informatics: Predictive analytics solution that provides hospitals with clinical outcome predictions and cost savings calculations based on evidence-based data from over 500 clinical study references
- T-SPeC
Products and services
- T-SPeC® (Transcutaneous Suprapubic Endoscopic Cystostomy) A single-use minimally invasive surgical instrument designed to enable suprapubic cystostomy catheter placement through a single small incision. Intended for urologists and surgical teams performing catheter placement procedures in hospital and outpatient surgical settings.
- Swan Informatics™ A predictive analytics platform associated with the company's urology product portfolio.
- Clinical Reference Access A clinical reference access offering associated with the company's urology portfolio.
Quantifiable outcome
- Procedure time of less than 10 minutes for suprapubic catheter placement
- +3 more outcomes
Companies that use Swan Valley Medical
Customer profileSegments3 records
Ideal customer profiles1 record
Swan Valley Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
Swan Valley Medical partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Swan Valley Medical competitors and assessment
Company assessmentBroad incumbents
- Cook Medical: Privately held medical device manufacturer with a substantial urology division offering catheters, access devices, and minimally invasive urological instruments. Comparable as a broad incumbent providing hospital urology departments with competing procedural devices.
- Hollister Incorporated: Privately held manufacturer of ostomy, continence, and urological products including catheters. Comparable as a broad incumbent in the continence/catheter category targeting overlapping hospital and patient populations.
- Coloplast: Global leader in urology and continence care, with a deep portfolio of catheters and urological devices sold directly to hospitals and end users. Comparable as a broad incumbent that competes in the same catheter/urology procurement budgets as Swan Valley's T-SPeC®.
- Boston Scientific: Major medical device manufacturer with a dedicated Urology and Pelvic Health business covering stone management, prostate health, and continence. Comparable as a broad incumbent operating in the same hospital urology purchasing decisions.
- Becton Dickinson (BD): Global medical technology company with a broad urology and interventional portfolio, including catheter and drainage products. Comparable as a broad incumbent competing in the same catheter procurement market segments.
- Convatec: Medical products company with a continence care business offering catheters and related urological devices. Comparable as a broad incumbent addressing hospital and home catheter users across overlapping indications.
- Teleflex: Diversified medical device company with a urology portfolio including catheters and urological specialty products. Comparable as a broad incumbent with established hospital sales channels that could absorb the suprapubic catheter niche.
Emerging players
- SRS Medical Systems: Specialty urology device company focused on diagnostic and therapeutic urological products. Comparable as a small, urology-focused peer with similar scale and hospital-customer overlap.
- Laborie Medical Technologies: Specialty urology and pelvic health company focused on diagnostics and therapeutic devices for urologists. Comparable as a niche-focused player with overlapping urology customers and similar go-to-market motion targeting hospital urology departments.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks7 records
Key highlights6 records
Customer concentration
Swan Valley Medical social profiles
Digital presenceSwan Valley Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Swan Valley Medical leadership team
Management profileNumber of profiles
Profiles8 records
Swan Valley Medical funding detail
Funding detailFunding overview
Funding rounds3 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Swan Valley Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Swan Valley Medical
What does Swan Valley Medical do?
Swan Valley Medical designs, develops, and manufactures single-use minimally invasive urological surgical instruments. Its flagship product, the T-SPeC® (Transcutaneous Suprapubic Endoscopic Cystostomy) system, enables suprapubic cystostomy catheter placement through a single small incision. The company also markets Swan Informatics™, a predictive analytics platform, alongside a Clinical Reference Access program for clinicians.
Is Swan Valley Medical a public or private company?
Swan Valley Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Swan Valley Medical founded?
Swan Valley Medical was founded in 2005. It employs 11 to 50 people.
Where is Swan Valley Medical based?
Swan Valley Medical is headquartered in Bigfork, United States, in the North America region.
How does Swan Valley Medical make money?
One revenue line is on record: medical Device Sales.
Who are Swan Valley Medical's main competitors?
Broad incumbents on record are Cook Medical, Hollister Incorporated, Coloplast, Boston Scientific, Becton Dickinson (BD), Convatec and Teleflex. Emerging players are SRS Medical Systems and Laborie Medical Technologies.
Does Swan Valley Medical have an API?
No public API is recorded for Swan Valley Medical.
What industry is Swan Valley Medical in?
Swan Valley Medical's product category is Urological Surgical Devices. Its primary akta.pro industry code is HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS), with a secondary code of HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 339112 and its SIC code is 3841.